2021 Revenues ($USD) : $125,733,000
2021 R&D spend : $16,956,000
2021 Number of Employees : 404
Fiscal Year End : 12/31/2020
Key People : Joseph Army, president and CEO; John Landry, SVP and CFO; Lindsay Becker, VP, human resources; David Blouin, VP, U.S. sales; John Coolidge, VP, operations; Marc Davidson, VP, strategic initiatives; Jill Dooling, VP, strategic accounts; George Dungan, VP, science and innovation; Richelle Helman, VP, quality, regulatory, R&D; James Lightman, SVP and general counsel; Michael McQueen, VP, medical education; Gregoire Ramade, SVP and chief commercial officer.

About the company: Vapotherm was founded in Stevensville, Maryland, in 1999 as a medical device manufacturer after creating the first heated and humidified high-flow therapy nasal cannula system. Now headquartered in Exeter, New Hampshire, with hundreds of employees headed by President and CEO Joe Army, Vapotherm develops high-velocity “Mask-Free NIV” therapy for those who are on ventilatory support and are mask-intolerant, risking failed treatment with rising costs of care and care escalation. Vapotherm designed its technology to allow patients to eat, drink, talk and take oral medications while receiving ventilatory and oxygenation support. –SW